Genic Co., Ltd. (KOSDAQ:123330)
South Korea · Delayed Price · Currency is KRW 23,450
+900 (3.99%)
At close: Jun 4, 2026
Genic Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 89,727 | 78,198 | 49,908 | 28,070 | 31,449 | 38,408 |
Other Revenue | -0 | -0 | - | -0 | - | - |
| 89,727 | 78,198 | 49,908 | 28,070 | 31,449 | 38,408 | |
Revenue Growth (YoY) | 46.20% | 56.68% | 77.80% | -10.75% | -18.12% | -8.84% |
Cost of Revenue | 66,904 | 55,653 | 38,297 | 24,836 | 28,750 | 31,491 |
Gross Profit | 22,823 | 22,545 | 11,611 | 3,234 | 2,699 | 6,918 |
Selling, General & Admin | 6,100 | 5,675 | 4,111 | 5,944 | 4,283 | 9,576 |
Research & Development | 1,604 | 1,498 | 981.36 | 1,078 | 1,059 | 1,134 |
Amortization of Goodwill & Intangibles | 1.68 | 1.1 | 3.89 | 5.02 | 31.1 | 76.86 |
Operating Expenses | 8,197 | 7,569 | 5,586 | 7,254 | 5,548 | 10,858 |
Operating Income | 14,626 | 14,976 | 6,025 | -4,021 | -2,850 | -3,940 |
Interest Expense | -329.13 | -329.13 | -413.12 | -413.39 | -477.42 | -690.45 |
Interest & Investment Income | 142.2 | 142.2 | 39.4 | 33.79 | 73.69 | 33.9 |
Currency Exchange Gain (Loss) | -18.29 | -18.29 | 67.59 | 851.98 | -507.93 | -596.08 |
Other Non Operating Income (Expenses) | 209.95 | 44.3 | -40.38 | -862.19 | 775.25 | 838.95 |
EBT Excluding Unusual Items | 14,630 | 14,815 | 5,679 | -4,411 | -2,986 | -4,354 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 154.15 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 2.99 | -0.01 | 0.74 | -0 |
Asset Writedown | - | - | - | - | -354.74 | - |
Pretax Income | 14,630 | 14,815 | 5,682 | -4,411 | -3,340 | -4,199 |
Income Tax Expense | -4,217 | -4,072 | -1,881 | - | - | - |
Earnings From Continuing Operations | 18,847 | 18,887 | 7,563 | -4,411 | -3,340 | -4,199 |
Earnings From Discontinued Operations | - | - | - | - | - | -131.11 |
Net Income | 18,847 | 18,887 | 7,563 | -4,411 | -3,340 | -4,331 |
Net Income to Common | 18,847 | 18,887 | 7,563 | -4,411 | -3,340 | -4,331 |
Net Income Growth | 60.99% | 149.73% | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Change (YoY) | 3.64% | 7.19% | 6.47% | - | - | - |
EPS (Basic) | 2408.73 | 2413.72 | 1036.00 | -643.32 | -487.17 | -631.65 |
EPS (Diluted) | 2408.73 | 2413.72 | 1036.00 | -643.32 | -487.17 | -631.65 |
EPS Growth | 55.33% | 132.98% | - | - | - | - |
Free Cash Flow | 5,711 | 17,980 | -1,379 | -1,110 | -1,237 | 1,921 |
Free Cash Flow Per Share | 729.94 | 2297.83 | -188.85 | -161.85 | -180.41 | 280.17 |
Gross Margin | 25.44% | 28.83% | 23.27% | 11.52% | 8.58% | 18.01% |
Operating Margin | 16.30% | 19.15% | 12.07% | -14.32% | -9.06% | -10.26% |
Profit Margin | 21.00% | 24.15% | 15.15% | -15.71% | -10.62% | -11.28% |
Free Cash Flow Margin | 6.37% | 22.99% | -2.76% | -3.95% | -3.93% | 5.00% |
EBITDA | 16,826 | 16,945 | 7,662 | -2,220 | -966.17 | -1,627 |
EBITDA Margin | 18.75% | 21.67% | 15.35% | -7.91% | -3.07% | -4.24% |
D&A For EBITDA | 2,200 | 1,969 | 1,637 | 1,801 | 1,883 | 2,313 |
EBIT | 14,626 | 14,976 | 6,025 | -4,021 | -2,850 | -3,940 |
EBIT Margin | 16.30% | 19.15% | 12.07% | -14.32% | -9.06% | -10.26% |
Advertising Expenses | - | 32.23 | 42.9 | 675.26 | -778.08 | 3,671 |